Insider Trading & Ownership of Michael Aaron Kelly

Location: New York, NY
Summary: The estimated net worth of Michael Aaron Kelly is at least $1,143,848 dollars as of 14 May 2026. Michael Aaron Kelly is the Director of NEOGENOMICS INC and owns shares of NEOGENOMICS INC (NEO) stock worth about $785.2K. Michael Aaron Kelly is the Director of DMC Global Inc. and owns shares of DMC Global Inc. (BOOM) stock worth about $341.7K. Michael Aaron Kelly is the Director of Aprea Therapeutics, Inc. and owns shares of Aprea Therapeutics, Inc. (APRE) stock worth about $17K.
Signature: /s/ Lindsey Rhodes, by Power of Attorney
All Insider Reports: All Insider Reports

Follow Filing Activity

Follow Michael Aaron Kelly and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Key facts

Michael Aaron Kelly has 6 issuer positions tracked on this page.
Estimated disclosed ownership value: $1,143,848.
Recent insider filing activity is available below.

Change

Largest disclosed position: NEOGENOMICS INC ($785,156).
Past-year value change for that position: +$38,000.

Research use

This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
You can cross-check role, issuer, and filing chronology directly against the SEC source.